Trial
NCT03879798
DS-3201b and Irinotecan for Patients With Recurrent Small Cell Lung Cancer
Phase ITERMINATEDSAFETYConfidence: HIGH
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
—
Condition
Small Cell Lung Cancer
Intervention
DS-3201b
Why stopped
Due to DLTs
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-10-10